UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Number of drug addicts reached 77,000 in past 5 years
Drug abuse is emerging as a serious problem in Korea with the number of dru...
by Lee Han-soo
|
2019-08-19 18:00
라인
Korea to provide ₩100 billion annually for 3 new industries
The government said it would prove more than 100 billion won ($82.4 million...
by Song Soo-youn
|
2019-08-14 14:52
라인
Drug regulator to enhance clinical trial management by 2023
The Ministry of Food and Drug Safety on Thursday announced a “Comprehensive...
by Lee Hye-seon
|
2019-08-08 14:55
라인
Japan’s 'whitelist’ removal to have minimal effect on biopharmaceutical sector
The local biopharmaceutical industry expects that Japan’s decision to remov...
by Lee Han-soo
|
2019-08-02 17:14
라인
Childbirth continues to hit new lows in Korea
The number of births and marriages hit new lows in May, as Korea's chil...
by Lee Han-soo
|
2019-08-01 18:09
라인
Pfizer's Besponsa, Takeda's Zejula likely to get insurance coverage
Pfizer's Besponsa, a B-cell lymphoblastic leukemia treatment, and Taked...
by Lee Han-soo
|
2019-07-26 17:57
라인
Biotech industry group urges Japan to withdraw export curbs
Korea Biotechnology Industry Organization has delivered a written request t...
by Jeong Sae-im
|
2019-07-25 17:09
라인
Doctor-patient telemedicine allowed as 1st step of Moon’s regulation-free zones
Telemedicine between doctors and patients will be allowed in Gangwon Provin...
by Kwak Sung-sun
|
2019-07-24 18:02
라인
Korea to set aside ₩3.5 trillion to support new drug development
Government agencies related to new drug development have outlined the "Nati...
by Jeong Sae-im
|
2019-07-24 11:59
라인
Regulator approves P3 trials for RSV treatment with extended half-life
Phase 3 clinical trials of Nirsevimab, a treatment for the respiratory sync...
by Lee Hye-seon
|
2019-07-23 11:08
라인
Physicians hit street to demand special law for medical accidents
About 400 physicians protested against a court ruling, holding pickets that...
by Song Soo-youn
|
2019-07-22 18:27
라인
Korean visit hospitals most frequently in OECD despite fewest physicians
Korea showed mixed results in the 2019 Organization for Economic Cooperatio...
by Lee Han-soo
|
2019-07-22 17:36
라인
Migrant worker group lashes mandatory health insurance subscription for foreigners
Foreigners who stay longer than six months in Korea will have to subscribe ...
by Lee Han-soo
|
2019-07-18 17:46
라인
Government employee stages one-person protest against own ministry
Kang Yoon-hee has been working as a committee member of the Clinical Trial ...
by Lee Hye-seon
|
2019-07-18 17:07
라인
Ministry extends data submission for cell therapy CureSkin
The drug regulator said it has granted S.Biomedics to extend the submission...
by Lee Hye-seon
|
2019-07-15 14:35
라인
Government faces uphill battle to look into Medytox over illicit drug
The Ministry of Food and Drug Safety said it would conduct a comprehensive ...
by Jeong Sae-im
|
2019-07-15 13:58
라인
Ministry to request investigation into Meditoxin approval process
The Ministry of Food and Drug Safety denied a suspicion that the ministry p...
by Lee Hye-seon
|
2019-07-12 16:29
라인
‘State lung cancer screening will raise false positive diagnoses’
The government has decided to add lung cancer to the state cancer screening...
by Kim Eun-young
|
2019-07-03 15:38
라인
Multinationals face suspension of drug imports
The regulator ordered multinational pharmaceutical firms, including MSD Kor...
by Lee Hye-seon
|
2019-07-01 14:12
라인
Government to help cover costs for injuries from side effects
The government said it would help patients get compensation for diseases ca...
by Lee Hye-seon
|
2019-06-28 12:30
-
이전
21
22
23
24
25
26
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top